Navigation Links
Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial
Date:7/23/2014

ors, including alternatives that may be more efficacious or cost-effective than any therapy or treatment that the company and its collaborators hope to develop, evaluation of potential opportunities, issues involving product liability, issues involving patents and whether they or licenses to them will provide the company with meaningful protection from others using the covered technologies, whether such proprietary rights are enforceable or defensible or infringe or allegedly infringe on rights of others or can withstand claims of invalidity and whether the company can finance or devote other significant resources that may be necessary to prosecute, protect or defend them, the level of corporate expenditures, assessments of the company's technology by potential corporate or other partners or collaborators, capital market conditions, the impact of government healthcare proposals and other factors set forth in our Annual Report on Form 10-K for the year ended December 31, 2013, our Form 10-Q for the quarter ended March 31, 2014, and other regulatory filings from time to time. There can be no assurance that any product in Inovio's pipeline will be successfully developed or manufactured, that final results of clinical studies will be supportive of regulatory approvals required to market licensed products, or that any of the forward-looking information provided herein will be proven accurate.

CONTACTS:
Investors: Bernie Hertel, Inovio Pharmaceuticals, 858-410-3101, bhertel@inovio.com
Media: Jeff Richardson, Inovio Pharmaceuticals, 267-440-4211, jrichardson@inovio.com

Logo - http://photos.prnewswire.com/prnh/20131118/LA18202LOGO


'/>"/>
SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
2. Inovio Pharmaceuticals Reports 2012 First Quarter Financial Results
3. Inovio Pharmaceuticals to Present at SPI 2012
4. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial
5. Inovio Pharmaceuticals to Present at JMP Investor Conference
6. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
7. Inovio Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on August 2nd
8. Inovio Pharmaceuticals Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
9. Inovio Pharmaceuticals Reports 2012 Second Quarter Financial Results
10. Inovio Pharmaceuticals Takes Major Stride Toward Universal Influenza Vaccine
11. Inovio Pharmaceuticals Reports 2012 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... , March 31, 2015  The efficacy of continuous ... in a recently published study 1 of ultraviolet ... research team, including Curtis Donskey , M.D.  The ... for the same length of time from the same ... unit.  The results showed surprisingly low pathogen kill rates ...
(Date:3/31/2015)... According to a new ... Market (Chromatography, Electrophoresis, DNA Sequencer, PCR, Microplate Reader, Robotics, ... Centrifuge) - Global Forecast to 2019", published by ... Market is expected to reach $48.84 Billion by ... 2019. Browse   9 ...
(Date:3/31/2015)... Calif. , March 31, 2015  Frequentz Inc., ... has released a white paper to help the pharmaceutical ... 2013 Drug Supply Chain Security Act (DSCSA). The white ... stages of the GS1 EPCIS Standard(s) and ... outlook on the product tracing requirements that need to ...
Breaking Medicine Technology:VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 2VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 3VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 4Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 2Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 3Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 4Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 5Frequentz Releases White Paper Addressing DSCSA's Current & Future Impact 2Frequentz Releases White Paper Addressing DSCSA's Current & Future Impact 3
... Causing Mitochondrial Disease More Common Than Previously,Believed, ... (UMDF) today announced landmark research finding that,one in ... could potentially cause a,mitochondrial disease in them or ... fatal disease, and mitochondrial disorders are at,the core ...
... Sanofi-aventis,(EURONEXT: SAN and NYSE: SNY) announced today ... priority review status for its New Drug,Application (NDA) ... July 31, 2008., The priority review is ... new drug product, if approved, has the potential ...
Cached Medicine Technology:New Research Shows One in 200 People Born with DNA Mutation That Can Lead to Devastating, Often Fatal Disease 2New Research Shows One in 200 People Born with DNA Mutation That Can Lead to Devastating, Often Fatal Disease 3Multaq(R) (dronedarone) Granted FDA Priority Review for Patients with Atrial Fibrillation 2Multaq(R) (dronedarone) Granted FDA Priority Review for Patients with Atrial Fibrillation 3
(Date:3/31/2015)... Indosoft, developer of the Q-Suite call center software ... of their 5.x line. The industry leading contact center ... the world for more than a decade. By announcing an ... Q-Suite can fully embrace newer Asterisk features and improve performance. ... Asterisk for more than a decade. The use of Asterisk, ...
(Date:3/31/2015)... March 31, 2015 Clinovo, a ... BayBio’s Membership Program , the premiere voice of ... 1300+ life science companies. , BayBio brings ... world’s most innovative and productive life science cluster, ... some of humanity’s most pressing challenges. , ...
(Date:3/31/2015)... Mirada, CA (PRWEB) March 31, 2015 ... treating hip injuries at all of their clinics. Specialties ... or disorders. , For athletes with hip injuries, ... ready to assess and treat the symptoms and underlying ... to provide minimally-invasive care and prevent future damage, while ...
(Date:3/31/2015)... Former 49ers linebacker Chris Borland turned more heads with ... a promising NFL career. In a March episode of ... Leitch explores the curious case of Borland and the ... making process that Borland and other football players will likely ... paycheck, and what impact, if any, he thinks this case ...
(Date:3/31/2015)... 2015 Array Health , a ... announced that Lance Hood, Senior Director of Marketing, will ... Forum on April 1, 2015. The session, co-presented with ... address how employers can streamline and simplify the private ... “ Optimizing Employee and Employer Needs in a Private ...
Breaking Medicine News(10 mins):Health News:Indosoft Announces End of Life for Asterisk 1.4 Support in Q-Suite 5 Call Center Software 2Health News:Clinovo Joins BayBio Membership Program, The Leading Life Science Association in Northern California 2Health News:Healthpointe Now Treating Hip Dislocations, Hip Fractures, Hip Bursitis, and Hip Strains at Locations in Southern California 2Health News:Will Leitch and the Curious Case of Chris Borland on SCI TV 2Health News:Will Leitch and the Curious Case of Chris Borland on SCI TV 3Health News:Array Health’s Senior Director of Marketing to Co-Present with Benaissance at The Institute for HealthCare Consumerism Private Exchange Forum 2
... this pregnancy complication , , MONDAY, July 21 (HealthDay News) ... in the world,s largest study of the possible genetic ... 5,000 people from families with an affected child and ... samples by taking cheek swabs from mothers and their ...
... planning with their doctor , , MONDAY, July 21 (HealthDay ... topiramate alone or in combination with other epilepsy drugs ... researchers report. , Topiramate (brand name Topamax) is ... It,s also used to treat migraine headaches. Many similar ...
... DURHAM, N.C. Researchers at Duke University Medical Center appear ... that has mystified physicians for years: why so many ... disease. , Clinicians first noted a relationship between the two ... anywhere from 50 to 90 percent of patients with asthma ...
... dental patient. Her oral health problems continue to change ... in Second Life,s virtual dental office. , The ... project of the Case Western Reserve University School of Dental ... communication sciences to teach and give students practice time to ...
... 2008 The question of whether insulin-producing cells of ... of diabetes, and to the further development of regenerative ... University Health Centre (MUHC) and McGill University together with ... de Montral (CHUM) have just concluded that they can. ...
... study at the Peninsula Medical School in Plymouth has reached ... of 493 people with multiple sclerosis (MS) has been recruited ... will evaluate whether tetrahydrocannabinol (THC), one of many compounds found ... ingredient) is able to slow the progression of MS. , ...
Cached Medicine News:Health News:Australian Study Seeks Genetic Roots of Cerebral Palsy 2Health News:Epilepsy Drug May Boost Birth Defect Risk 2Health News:Epilepsy Drug May Boost Birth Defect Risk 3Health News:Scientists identify how gastric reflux may trigger asthma 2Health News:A virtual toothache helps student dentists 2Health News:A virtual toothache helps student dentists 3Health News:Montreal researchers prove that insulin-producing cells can give rise to stem-like cells in-vitro 2Health News:Milestone for cannabinoid MS study 2
... designed to optimize the accuracy and precision ... products is widely recognized by customers throughout ... extended over the years and now covers ... tips including filter tips, certified pure tips, ...
... Processor is a primary component of an ... processing, sampling, and slide preparation all ... MonoPrep LBP Processor produces high-quality sample slides ... range of cytology specimen types. It processes ...
... innovative, quick and easy automated refill ... less space on your laboratory bench ... amazingly easy-to-use, one-hand system, you only ... range of Diamond Tips. All sizes ...
200 L, Racked, Pre-sterilized, 96 tips/rack, clear Recommended for 20, 25, 50, 100 and 200 L pipettes. Can also be used with 300 L pipettes when pipetting 200 L or less....
Medicine Products: